CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer KASINGER JAMES R.
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bruno Julianne
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kulkarni Samarth
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Prasad Raju
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer KASINGER JAMES R.
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kulkarni Samarth
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kulkarni Samarth
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bruno Julianne
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director George Simeon
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Treco Douglas A
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director High Katherine A
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Greene John
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mahatme Sandesh
CRISPR Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Rommel Christian
CRISPR Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Mahatme Sandesh
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Patel Naimish
CRISPR Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Patel Naimish
CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bruno Julianne
CRISPR Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Bruno Julianne
No Data
No Data